Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects

被引：0
|
作者：
David W. Boulton
Charles H. Smith
L. Li
Jian Huang
Angela Tang
Frank P. LaCreta
机构：
[1] Bristol-Myers Squibb,
[2] PPD,undefined
来源：
Clinical Drug Investigation | 2011年 / 31卷
关键词：
Metformin; Saxagliptin; Tablet Core; Healthy Adult Subject; Initial Combination Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and Objectives: As compared with individual tablets, saxagliptin/metformin extended-release (XR) fixed-dose combination (FDC) tablets offer potential for increased patient compliance with the convenience of once-daily dosing. Two bioequivalence studies assessed the fed-state bioequivalence of saxagliptin/metformin XR 5 mg/500 mg FDC (study 1) and saxagliptin/metformin XR 5mg/1000 mg FDC (study 2) relative to the same dosage strengths of individual component tablets administered concurrently. The effect of food on saxagliptin and metformin pharmacokinetics from the saxagliptin/metformin XR 5 mg/500 mg FDC and their steady-state pharmacokinetics from the saxagliptin/metformin XR 5 mg/1000 mg were also investigated.
引用
收藏
页码：619 / 630
页数：11
相关论文
共 50 条
  • [31] Bioequivalence of Ertugliflozin/Metformin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
    Dawra, Vikas Kumar
    Liang, Yali
    Wei, Hua
    Pelletier, Kathleen
    Shi, Haihong
    Hickman, Anne
    Bass, Almasa
    Terra, Steven G.
    Zhou, Susan
    Krishna, Rajesh
    Sahasrabudhe, Vaishali
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (01): : 50 - 61
  • [32] Pharmacokinetics of fixed-dose combinations of empagliflozin/metformin compared with individual tablets in healthy subjects
    Rojas, Christina
    Link, Jasmin
    Meinicke, Thomas
    Macha, Sreeraj
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 282 - 292
  • [33] BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN/METFORMIN EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CHINA
    Zhang, J.
    Xie, S.
    He, X.
    VALUE IN HEALTH, 2019, 22 : S145 - S145
  • [34] Bioequivalence Comparison of Two Formulations of Fixed-Dose Combination Glimepiride/Metformin (2/500 mg) Tablets in Healthy Volunteers
    Jung, Sang-hoon
    Chae, Jung-woo
    Song, Byung-jeong
    Kwon, Kwang-il
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (02): : 365 - 371
  • [35] Pharmacokinetic comparison of a fixed-dose combination of metformin/gliclazide versus coadministration of metformin and gliclazide as separate tablets in healthy male subjects.
    Lim, Y.
    Shin, H.
    Shim, M.
    Lim, M.
    Moon, D.
    Choi, Y.
    Lee, Y.
    Yoon, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S61 - S61
  • [36] In Vitro Dissolution and In Vivo Bioequivalence Evaluation of Two Metformin Extended-Release Tablets
    Zhou, Ziye
    Wang, Chenxiang
    Li, Min
    Lan, Qin
    Yu, Chao
    Yu, Guoxin
    Xia, Yan
    Chen, Huafang
    Zhang, Xiuhua
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (04): : 414 - 419
  • [37] SINGLE DOSE BIOEQUIVALENCE BETWEEN LEVETIRACETAM 2 x 750 MG XR TABLETS AND 3 x 500 MG XR TABLETS AND FOOD EFFECT ON 2 x 750 MG XR TABLETS IN HEALTHY SUBJECTS
    Otoul, Christian
    Rouits, Elisabeth
    Burton, I.
    Guenole, E.
    Troenaru, Mona
    Valgaeren, A.
    Boulanger, P.
    Sargentini-Maier, Maria Laura
    EPILEPSIA, 2008, 49 : 446 - 446
  • [38] SAXAGLIPTIN/METFORMIN EXTENDED-RELEASE (XR) FOR THE TYPE 2 DIABETES (T2DM) TREATMENT IN VENEZUELA: A BUDGET IMPACT ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Perez Monteverde, A.
    Garrido Lecca, S.
    Aiello, E.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A243 - A243
  • [39] Pharmacokinetic comparison of sitagliptin and metformin HCl extended-release tablets versus JANUMET® XR in healthy volunteers under fasting and fed conditions
    Que, Linling
    Qin, Wei
    Shi, Yunfei
    Ding, Ying
    Huang, Kai
    Qian, Zhenzhong
    Huang, Bingjie
    Zhou, Peipei
    He, Qing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed-Dose Combination Tablets to Canadian-Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States
    Dawra, Vikas Kumar
    Pelletier, Kathleen
    Matschke, Kyle
    Shi, Haihong
    Hickman, Anne
    Zhou, Susan
    Krishna, Rajesh
    Sahasrabudhe, Vaishali
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (05): : 510 - 520
12345